Javascript must be enabled to continue!
Setting Targets for HIV: An Evaluation of Indicator Quality and Target Achievement in National Strategic Plans
View through CrossRef
Background:
National Strategic Plans (NSPs) for HIV have become foundational documents that frame responses to HIV. Both Global Fund and PEPFAR require coordination with NSPs as a component of their operations. Despite the role of NSPs in country planning, no rigorous assessment of NSP targets and performance outcomes exists. We performed a quantitative analysis of the quality of NSP indicators and targets and assessed whether historical NSP targets had been achieved.
Methods:
All targets and indicators from publicly available NSPs from 35 countries are coded as structural, input, output, or impact indicators. Targets were evaluated for specificity, measurability, achievability, relevance, and being time-bound. In addition, progress toward achieving targets was evaluated using historical NSPs from 4 countries.
Results:
NSPs emphasized output indicators, but inclusion of structural, input, or impact indicators was highly variable. Most targets lack specificity in target population, numeric baselines or targets, and a data source for monitoring. Targets were, on average, 205% increases or decreases relative to baselines. Alignment with international indicators was variable. Metrics of indicator quality were not associated with NSP funding needs. Monitoring of historical NSP targets was limited by a lack of defined targets and available data.
Conclusions:
Country NSPs are limited by a lack of specific, measurable, and achievable targets. The low achievement of targets in historical NSPs corroborates that targets are often poorly defined and aspirational, and not linked to available data sources. NSP quality may be improved through better use of programmatic data and greater inclusion of targets for process measures.
Ovid Technologies (Wolters Kluwer Health)
Title: Setting Targets for HIV: An Evaluation of Indicator Quality and Target Achievement in National Strategic Plans
Description:
Background:
National Strategic Plans (NSPs) for HIV have become foundational documents that frame responses to HIV.
Both Global Fund and PEPFAR require coordination with NSPs as a component of their operations.
Despite the role of NSPs in country planning, no rigorous assessment of NSP targets and performance outcomes exists.
We performed a quantitative analysis of the quality of NSP indicators and targets and assessed whether historical NSP targets had been achieved.
Methods:
All targets and indicators from publicly available NSPs from 35 countries are coded as structural, input, output, or impact indicators.
Targets were evaluated for specificity, measurability, achievability, relevance, and being time-bound.
In addition, progress toward achieving targets was evaluated using historical NSPs from 4 countries.
Results:
NSPs emphasized output indicators, but inclusion of structural, input, or impact indicators was highly variable.
Most targets lack specificity in target population, numeric baselines or targets, and a data source for monitoring.
Targets were, on average, 205% increases or decreases relative to baselines.
Alignment with international indicators was variable.
Metrics of indicator quality were not associated with NSP funding needs.
Monitoring of historical NSP targets was limited by a lack of defined targets and available data.
Conclusions:
Country NSPs are limited by a lack of specific, measurable, and achievable targets.
The low achievement of targets in historical NSPs corroborates that targets are often poorly defined and aspirational, and not linked to available data sources.
NSP quality may be improved through better use of programmatic data and greater inclusion of targets for process measures.
Related Results
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Background: The HIV pandemic has attracted unprecedented scale-up in resources to curb its escalation and manage those afflicted. Although evidence from developing countries sugges...
Evaluasi peningkatan pengetahuan tentang HIV/AIDS dan sikap terhadap ODHA di SMK Gelora Jaya Nusantara
Evaluasi peningkatan pengetahuan tentang HIV/AIDS dan sikap terhadap ODHA di SMK Gelora Jaya Nusantara
Background: HIV/AIDS remains a global health problem in Indonesia, with major barriers being misunderstandings, social stigma, and ineffective educational approaches. The level of ...
Spatial immune dynamics in mucosal HIV infection
Spatial immune dynamics in mucosal HIV infection
<p dir="ltr">Sexual transmission is the most common mode of HIV infection, making the female genital and rectal tracts critical mucosal sites for preventing HIV transmission....
Spatial immune dynamics in mucosal HIV infection
Spatial immune dynamics in mucosal HIV infection
<p dir="ltr">Sexual transmission is the most common mode of HIV infection, making the female genital and rectal tracts critical mucosal sites for preventing HIV transmission....
Abstract 5594: Progression of paraproteinemia in HIV-positive versus HIV-negative patients
Abstract 5594: Progression of paraproteinemia in HIV-positive versus HIV-negative patients
Abstract
BACKGROUND: Paraproteinemias occur in 1 to 3% of people over the age of 50 and progress to hematological malignancies (HM) at the rate of about 1% per year....

